Based on 2 analysts giving stock ratings to Health In Tech Inc in the past month.
In the current month, HIT has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HIT average Analyst price target in the last month is 3.700.
Based on analysts' estimates, HIT EPS is projected to reach -0.030 in FY2026Q3, following reported EPS of -0.040 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.04, while Health In Tech IncHIT's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD -0.03.